Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Insulin Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Wockhardt Ltd
Eli Lilly and Company
Biocon
Julphar
Novo Nordisk A/S
9Bioton SA
AstraZeneca PLC
Sanofi-Aventis
Merck & Co, Inc
By Type:
Long-acting Insulin
Intermediate-acting Insulin
Premixed Insulin
Short-acting Insulin
By Application:
Branded Drugs
Generic Drugs
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Insulin Therapeutics Market Overview 2018-2029
-
1.1 China Insulin Therapeutics Industry Development Overview
-
1.2 China Insulin Therapeutics Industry Development History
-
1.3 China Insulin Therapeutics Industry Market Size (2018-2029)
-
1.4 China Insulin Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Long-acting Insulin (2018-2029)
-
1.4.2 China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Intermediate-acting Insulin (2018-2029)
-
1.4.3 China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Premixed Insulin (2018-2029)
-
1.4.4 China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Short-acting Insulin (2018-2029)
-
1.5 China Insulin Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Insulin Therapeutics Sales Volume, Sales Value and Growth Rate of Branded Drugs (2018-2029)
-
1.5.2 China Insulin Therapeutics Sales Volume, Sales Value and Growth Rate of Generic Drugs (2018-2029)
-
1.6 China Insulin Therapeutics Market Analysis by Region
-
1.6.1 North China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Insulin Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Insulin Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Insulin Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Insulin Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Insulin Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Insulin Therapeutics Industry Development
Chapter 3 Insulin TherapeuticsIndustry Chain Analysis
-
3.1 Insulin Therapeutics Industry Chain
-
3.2 Insulin Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Insulin Therapeutics Market
-
3.3 Insulin Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Insulin Therapeutics Market
Chapter 4 China Insulin Therapeutics Market, by Type
-
4.1 China Insulin Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Insulin Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Insulin Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Insulin Therapeutics Production Volume and Growth Rate of Long-acting Insulin
-
4.5.2 China Insulin Therapeutics Production Volume and Growth Rate of Intermediate-acting Insulin
-
4.5.3 China Insulin Therapeutics Production Volume and Growth Rate of Premixed Insulin
-
4.5.4 China Insulin Therapeutics Production Volume and Growth Rate of Short-acting Insulin
Chapter 5 China Insulin Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Insulin Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Insulin Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Insulin Therapeutics Market Size and Growth Rate of Branded Drugs
-
5.5.2 China Insulin Therapeutics Market Size and Growth Rate of Generic Drugs
Chapter 6 China Insulin Therapeutics Market, by Region
-
6.1 China Insulin Therapeutics Production Volume and Production Value, by Region
-
6.2 China Insulin Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Insulin Therapeutics Market Analysis
-
7.1 North China Insulin Therapeutics Market, by Type
-
7.2 North China Insulin Therapeutics Market, by Application
Chapter 8 Central China Insulin Therapeutics Market Analysis
-
8.1 Central China Insulin Therapeutics Market, by Type
-
8.2 Central China Insulin Therapeutics Market, by Application
Chapter 9 South China Insulin Therapeutics Market Analysis
-
9.1 South China Insulin Therapeutics Market, by Type
-
9.2 South China Insulin Therapeutics Market, by Application
Chapter 10 East China Insulin Therapeutics Market Analysis
-
10.1 East China Insulin Therapeutics Market, by Type
-
10.2 East China Insulin Therapeutics Market, by Application
Chapter 11 Northeast China Insulin Therapeutics Market Analysis
-
11.1 Northeast China Insulin Therapeutics Market, by Type
-
11.2 Northeast China Insulin Therapeutics Market, by Application
Chapter 12 Southwest China Insulin Therapeutics Market Analysis
-
12.1 Southwest China Insulin Therapeutics Market, by Type
-
12.2 Southwest China Insulin Therapeutics Market, by Application
Chapter 13 Northwest China Insulin Therapeutics Market Analysis
-
13.1 Northwest China Insulin Therapeutics Market, by Type
-
13.2 Northwest China Insulin Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 Wockhardt Ltd
-
14.1.1 Wockhardt Ltd Company Profile
-
14.1.2 Wockhardt Ltd Insulin Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Eli Lilly and Company
-
14.2.1 Eli Lilly and Company Company Profile
-
14.2.2 Eli Lilly and Company Insulin Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Biocon
-
14.3.1 Biocon Company Profile
-
14.3.2 Biocon Insulin Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Julphar
-
14.4.1 Julphar Company Profile
-
14.4.2 Julphar Insulin Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Novo Nordisk A/S
-
14.5.1 Novo Nordisk A/S Company Profile
-
14.5.2 Novo Nordisk A/S Insulin Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 9Bioton SA
-
14.6.1 9Bioton SA Company Profile
-
14.6.2 9Bioton SA Insulin Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 AstraZeneca PLC
-
14.7.1 AstraZeneca PLC Company Profile
-
14.7.2 AstraZeneca PLC Insulin Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sanofi-Aventis
-
14.8.1 Sanofi-Aventis Company Profile
-
14.8.2 Sanofi-Aventis Insulin Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Merck & Co, Inc
-
14.9.1 Merck & Co, Inc Company Profile
-
14.9.2 Merck & Co, Inc Insulin Therapeutics Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Insulin Therapeutics Industry Research Conclusions
-
15.2 Insulin Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Insulin Therapeutics Industry Market Size (2018-2029)
-
Figure China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Long-acting Insulin (2018-2029)
-
Figure China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Intermediate-acting Insulin (2018-2029)
-
Figure China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Premixed Insulin (2018-2029)
-
Figure China Insulin Therapeutics Production Volume, Production Value and Growth Rate of Short-acting Insulin (2018-2029)
-
Figure China Insulin Therapeutics Sales Volume, Sales Value and Growth Rate of Branded Drugs (2018-2029)
-
Figure China Insulin Therapeutics Sales Volume, Sales Value and Growth Rate of Generic Drugs (2018-2029)
-
Figure North China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Insulin Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Insulin Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Insulin Therapeutics Market Share by Type in 2018
-
Figure China Insulin Therapeutics Market Share by Type in 2023
-
Figure China Insulin Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Insulin Therapeutics Production Volume and Growth Rate of Long-acting Insulin (2018-2023)
-
Figure China Insulin Therapeutics Production Volume and Growth Rate of Intermediate-acting Insulin (2018-2023)
-
Figure China Insulin Therapeutics Production Volume and Growth Rate of Premixed Insulin (2018-2023)
-
Figure China Insulin Therapeutics Production Volume and Growth Rate of Short-acting Insulin (2018-2023)
-
Figure China Insulin Therapeutics Market Share by Application in 2018
-
Figure China Insulin Therapeutics Market Share by Application in 2023
-
Figure China Insulin Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Insulin Therapeutics Market Size and Growth Rate of Branded Drugs (2018-2023)
-
Figure China Insulin Therapeutics Market Size and Growth Rate of Generic Drugs (2018-2023)
-
Table China Insulin Therapeutics Production Volume by Region (2018-2023)
-
Table China Insulin Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Insulin Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Insulin Therapeutics Production Value by Region (2018-2023)
-
Table China Insulin Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Insulin Therapeutics Production Value Share by Region (2018-2023)
-
Table China Insulin Therapeutics Sales Volume by Region (2018-2023)
-
Table China Insulin Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Insulin Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Insulin Therapeutics Sales Value by Region (2018-2023)
-
Table China Insulin Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Insulin Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Insulin Therapeutics Production Volume by Type (2018-2023)
-
Table North China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Insulin Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Insulin Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Insulin Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Insulin Therapeutics Production Volume by Type (2018-2023)
-
Table South China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Insulin Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Insulin Therapeutics Production Volume by Type (2018-2023)
-
Table East China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Insulin Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Insulin Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Insulin Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Insulin Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Insulin Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Insulin Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Insulin Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Insulin Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Insulin Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Wockhardt Ltd Company Profile
-
Table Wockhardt Ltd Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Biocon Company Profile
-
Table Biocon Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Julphar Company Profile
-
Table Julphar Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Novo Nordisk A/S Company Profile
-
Table Novo Nordisk A/S Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table 9Bioton SA Company Profile
-
Table 9Bioton SA Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca PLC Company Profile
-
Table AstraZeneca PLC Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Sanofi-Aventis Company Profile
-
Table Sanofi-Aventis Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Merck & Co, Inc Company Profile
-
Table Merck & Co, Inc Insulin Therapeutics Revenue, Price and Gross (2018-2023)
-
